Blend Labs financials
$1.03−5.50%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $33.8M | $30.8M | $32.4M | $32.9M | $31.6M | $26.8M | $30.1M | $33.1M | $28.7M | $23.8M | $36.1M | $40.6M |
| Gross profit | $24.9M | $23.4M | $24.4M | $24.5M | $23.4M | $19.0M | $22.3M | $24.5M | $20.3M | $16.0M | $19.7M | $22.1M |
| Gross margin | 73.5% | 75.8% | 75.4% | 74.4% | 73.8% | 70.8% | 74.2% | 74.0% | 70.9% | 67.3% | 54.6% | 54.4% |
| Operating income | -$1.6M | -$5.1M | -$4.5M | -$4.9M | -$4.8M | -$8.0M | -$3.3M | -$11.3M | -$13.1M | -$21.2M | -$21.9M | -$36.2M |
| Net income | -$6.4M | -$12.8M | -$8.2M | $8.0M | -$11.2M | -$15.0M | -$6.5M | -$8.3M | -$23.6M | -$22.1M | -$31.8M | -$43.2M |
| Net margin | −18.9% | −41.4% | −25.1% | 24.3% | −35.5% | −55.8% | −21.6% | −24.9% | −82.2% | −92.8% | −88.1% | −106.5% |
| Diluted EPS | $-0.03 | $-0.05 | $-0.03 | $0.02 | $-0.04 | $-0.06 | $-0.03 | $-0.03 | $-0.09 | $-0.09 | $-0.13 | $-0.18 |
| EBITDA | -$533.0K | -$2.6M | -$1.6M | -$4.5M | -$4.5M | -$6.5M | -$1.8M | -$6.7M | -$12.4M | -$19.7M | -$21.2M | -$25.8M |
| Operating cash flow | $7.9M | $7.4M | $980.0K | -$3.5M | -$6.5M | $20.1M | -$4.6M | $2.1M | -$6.7M | -$3.9M | -$20.7M | -$25.9M |
| Free cash flow | $7.1M | $6.2M | -$21.0K | -$5.8M | -$10.1M | $15.8M | -$7.1M | -$1.4M | -$8.5M | -$5.8M | -$20.8M | -$25.9M |
| Diluted shares | 239.9M | 255.6M | 249.0M | 268.7M | 259.2M | 258.8M | 256.8M | 254.9M | 253.1M | 250.9M | 248.7M | 246.4M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $23.3M | $37.4M | $45.1M | $55.0M | $36.5M | $56.2M |
| Short-term investments | $21.6M | $21.6M | $24.7M | $22.2M | $51.8M | $48.6M |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $143.6M | $161.3M | $170.0M | $189.6M | $183.1M | $188.3M |
| Total liabilities | $48.8M | $52.9M | $41.0M | $47.3M | $55.4M | $59.3M |
| Shareholders' equity | $94.8M | -$55.9M | $129.0M | -$12.5M | -$22.6M | -$16.9M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology